Yu-Chang Liu
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 01, 2025
Imipramine Inhibits Osteosarcoma Invasion via Src Inactivation and Caspase-Dependent Apoptosis.Yu-Chang Liu, Chi-Jung Fang, Li-Cho Hsu
|Aug 20, 2025
Magnolol as a Radiotherapy Enhancer in Oral Squamous Cell Carcinoma: Targeting the EGFR/NF-κB Pathway and Immune Modulation.Yu-Chang Liu, Chih-Ying Liao, Fei-Ting Hsu
|May 13, 2023
Inactivation of EGFR/ERK/NF-κB signalling associates with radiosensitizing effect of 18β-glycyrrhetinic acid on progression of hepatocellular carcinoma.Yu-Chang Liu, Cheng Hsun Lin, Kuan-Tin Chen
|Apr 30, 2021
Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma.Fei-Ting Hsu, Yu-Chang Liu, Chang-Liang Tsai
|Jun 27, 2019
Protein Kinase B and Extracellular Signal-Regulated Kinase Inactivation is Associated with Regorafenib-Induced Inhibition of Osteosarcoma Progression In Vitro and In Vivo.Po-Jung Pan, Yu-Chang Liu, Fei-Ting Hsu
|Feb 14, 2019
Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.Wei-Ting Chen, Fei-Ting Hsu, Yu-Chang Liu
Pageof 1
